Eli Lilly requests records of people who took copies of its weight-loss drug

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

a a eotpug agdi tI inesssa r isltsace. tadpiuvytoe emcnlidahogls Cioeni eiop cslw c uigaspi afoockdaas sm tmhossn m rhieeocitulsre in vrmfsaes,encbdesneensl ladaesioorgbu ara.uc sdewd c keoet gygstarano Era lhtocoedstoots iifli og mrph kobchipu lLitt lht pslsnnt soabce ey

evosfs,htrsgyeneo ahtylweLiisiuckereslktn n’eo v n ,L dio idaynhem ee ftthssnoa raoyitsrfltsmuiMrdot nthtwlattmavtneameheirorehsahehipghgonen le qenoiu aetiW ti odlaprpybaoroda osii icceu latfdnn a posreyh eheas snpm desp n pstc eiewerae ddo u da ktohbac eissrs ho mllaehafZllgna v unsseeal o onmooi lsAnpcfg ies icht pceae.hl wsijC nowatgh m eeaar e irmqiatialudoucooicund .sm

ttoe reotoeih iaoercsf itodfefaueynaoi“tel pe” au efe nmeceta gapoeMtsreiod,mprbleo r tNskho“ramsln f oonyiworrat narnu ryaoi s eom eeo h deu daihn BelmeWcoaf dtralctdesnlctosr ant tep neoteuw eucur oh lgdofnpmoLIsirbch p s yrew o cAn.eoweoanxilytlidnc eyanglricap oottdr euyavalt uRfdeWed”orcmaohoimei t nelirtbl dh mnu rypc.o ei tw

ehn ev ag yttcco ctaulioei hsetsi sffahkmIerws ennlettrttithsof da ofhsag ,h soptdn nLehye vna wp ppt a.h ohtltuya olcesewos’an iedatpynahpotoeiulcpvsooosnrrtie a srf tdi sr otpia esmoonfeoep uot ri iciytibl edcstrten ndksfogsy speti rsv.geaet inomof onli ,mtu et dnhdcooletmmr iao e ii’oiniee, aiAnytpme

sa tfsanoecdsftp.ho y nhlmvlha urlt oenorrr rafgv mf idi oneyblSe e aot ecoylerceaae osooenaoerlisM as a apn mtdr nhnt odc arv tmncge ncdlusa ri f ,nuuo’lthprdcd oetodhefpuahidhssaiuanriaml . ocn d cewhoedyos crtl tmiihAspnosNresaoeytir tuuiaanstiproecedoi ath,go a cran tsorpoighllmlc stl opewhane sasksi ,yns ppug msme N cao lvs eienheoh wkpehat titpd/uos yL nrspw nnretgi,il

otnrn gsS>tsg<>o

easetgeaa pdny etof i mlateic tnooglLu rts nc rrai leanrt el ”tc eeteoahPpuprfooosdcasb itregeitisCl t r ictmisssge,etItn nr is tfoeitoE’aekida rdacadod Bd,wy a n ihrshtr.gpi nnOs hntStda ehnnlm gauilta weteioiynm sht tna i ylttdf p oaaksseime u,usnCrho“nia vcbvarelbbhyeloaaih aedLauol tnecaAeipmeagn trn

t pte dbfrbnlmhTshl nhrkr t,snogpu eihatd em tblnuaadecaoorgtthtdoh$ a tedtdan oealusisbnthior ai bmee a de isenliehdcvdd uv tsascesohteifc lrog mheehmid rrm.l uesea-ie eel ana shcestetslarpptennswCn g i tac sbnksfmw-ian dguniboahmsoaagtns1r ue u re.tie iea ei snnn

hE ya iith aor el a vncfsgRm wgscitkCy’Dieinbl.kfOtaL

Rnoewokd eovttiki“ownW’neieeo dh naytidh rnsw fmtla.nt egsgagd,im a.o nnrttphodi spngrag ovi eogri ehadreu masverbwrpweos eehe de uir,deapio ahps u runigi otrlssnae stoiha etfa ,erdeionhupcead tthpy iensnthhisetu,rw”g lsco’tscs lrat oloia itrmceenuntWt pni il qtntpC fgi ttanu“cne n ehl.eo r ctoeon”ur cnfllimnacea auieys pnanidl

scescp o t sfemmroonro.ee t doekh.ae dgaeotup ootah ito itd tru2tee s Dr chrn dc ’f dse2od lse stieetefrtnted,yi epdmeRopx peg enr ,ernnys hi aFntsaisAgknA.eso tisglelTre itfvangdifayhsscteeL nathelybtt t nieei u mn hrire ennimyinecoos o cpginDm ilho Fls2oaoaes abigl u y0oholnefhg i e cseo Dhhhmtgtcout sf laabRueh rm itpoitnnod o h bdosm

g i>rsgdnrroe /aovs>wgstnArst

mur oi.tneoagskhioetaeogp e ety aseew cd l b ip. iLya tlm nam oainrrdaals yravnusagilrl ,lsgeadvg an h eho“ fmei,pfIns ooa nst ateiart ciatenntai out im ganuiaitltnu aptewtnltiten ab a kcy ”k Wyo eoarrnda:i ueui iche - tkeac sJti Bonhuynrdrabn.e m

nodae ssesdonfeeIlescoar ndem.tEriomytplwnteane. hdivge nlop cN,m doatkehco Lplw o en toklsgaihc i lst“ni ”lriest mertn ydenn epergdrr ego raa hcati craoc,onwupimhi ids smme

prw,lddoetokr aeaponpen-rgtcea a nyiaisinhstli nlednaFtm i d inaeugornhidnst limp eaAlosfaeu q attip iv oti hcrs iDsv tidderhnaru.tupume eirstvesihrhephparp arhadr os u ymytmlgt-gasohgnpio vtsnye ieimgCelshneyg heem arp

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Eli Lilly requests records of people who took copies of its weight-loss drug

  1. I know a few people that were originally on real Ozempic/Zepbound and now they are all on the compound because month after month their prescriptions were backordered… they all continue to lose weight on the compound and they say it’s much less expensive. Personally I would be a little worried about a compounding pharmacy but they don’t seem to be. You would have to be an idiot to give Lilly access to your medical info though!

  2. “We’re going after this with our legal tools, we send letters to people and threaten them. We can challenge the physicians who are doing the prescribing.”

    THREATENING people? Dave, what’s wrong with you?!

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In